Human Formulations

Spironolactone 100mg Tab. (Uncoated)

Spironolactone 100mg Tab. (Uncoated) is a tablet formulated with Spironolactone 100mg . ( ). The listed active ingredient profile is Spironolactone, placing the product in the potassium-sparing diuretic category. The formulation contains a potassium-spari

Therapeutic RangesCardiac Range Single Ingredient Tablet
Sterile injectable formulation

Product information

Product Line
Human Formulations
Category
Therapeutic Ranges, Cardiac Range
Dosage Form
Tablet
Product Type
Single Ingredient

Available strengths

Spironolactone 100mg . ( )

Description

Spironolactone 100mg Tab. (Uncoated) is a tablet formulated with Spironolactone 100mg . ( ). The listed active ingredient profile is Spironolactone, placing the product in the potassium-sparing diuretic category. The formulation contains a potassium-sparing diuretic used in selected fluid-retention and cardiovascular conditions. The source identifies the dosage form as tablet with uncoated presentation. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.
WHO-GMP Sourced
Sterile Supply
Regulatory Documentation
Quality Assured